{
    "Trade/Device Name(s)": [
        "PixoTest Blood Glucose Monitoring System"
    ],
    "Submitter Information": "iXensor Co. Ltd.",
    "510(k) Number": "K163087",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021827"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "October 25, 2017",
    "Summary Letter Received Date": "October 30, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "PixoHealth App (iPhone 5/5S/6/6S)",
        "PixoTest Glucose Test Strip",
        "PixoTest Uni-Clip"
    ],
    "Method(s)/Technology(ies)": [
        "Reflectance photometry",
        "Glucose oxidase chemical reaction"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Accessory",
        "App"
    ],
    "Document Summary": "FDA 510(k) summary for PixoTest Blood Glucose Monitoring System using glucose oxidase and smartphone-based reflectance photometry for measuring blood glucose.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from the fingertip by people with diabetes at home as an aid to monitor diabetes control; for single person use only and not for diagnosis, screening, or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}